Seminars and webinars

Latest seminars and webinars organised by FinPharmaNet.

We­binars take place every Tues­days via Zoom at 3 pm  or 4 pm (Helsinki time; EST). Max time 45 min + 15 min dis­cus­sion.

Webinares hosted by Prof. Mikko Airavaara, Faculty of Pharmacy, University of Helsinki.
Upcoming seminars
Past seminars
  • Dr. Rana Rais ( Johns Hop­kins Medicine, Bal­timore, MD, USA)
    • 1.2.2022 at 3 pm, Glutamine Antagonist Prodrug Discovery: “A story of BENCH 2 BEDSIDE”
  • Pro­fessor Rajesh K. Ma­hesh­wari S.G.S.I.T.S., In­dia
    • 8.3.2022, 3 pm; Novel applications of solubilizing properties of safe and economic solids in various fields of pharmacy giving green methods minimizing the use of harmful organic solvents"
  • Dr. Eric M Prager (As­so­ci­ate Dir­ector, Trans­la­tional Research & De­vel­op­ment, Co­hen Vet­er­ans Bios­cience)
    • 15.3.2022, 4 pm; A Framework to Optimize Research Rigor and Reproducibility
  • Prof. Elisa­bet Jer­l­hag (University of Gothen­burg, Sweden)
    • 29.3.2022, 3 pm; Gut brain axis in alcohol use disorder
  • Dr. Mat­thias Herth (University of Copen­ha­gen, Den­mark)
    • 5.4.2022, 3pm; The Tetrazine Ligation - A bioorthogonal reaction for Organic Chemistry in humans
  • Prof. Risto Kaaja (University of Turku, Fin­land)
    • 19.4.2022; 3 pm.; Pregnancy - window to woman's health offering possibility to primary prevention.
  • Dr. Anna Er­landsson (De­part­ment of Pub­lic Health and Caring Sciences, Uppsala University, Sweden)
    • 26.4.2022, 3 pm.; Astrocytes - a possible treatment target to halt Alzheimer’s disease progression
  • Dr. Kert Mät­lik (Rock­e­feller University, New York, USA)
    • 3.5.2022, 3 pm; Cell type-specific vulnerability of striatal neurons in Huntington's disease
  • Prof. Poul Hen­ning Jensen, M.D., Dr. Med. Sci. Aar­hus University, Dept. of Bio­medi­cine & DANDRITE, Dan­ish Research In­sti­tute of Trans­la­tional Neuroscience
    • 10.5.2022, 3 pm; New non-inclusion a-syn aggregate neuropathology – how to detect it, does it matter and can we counteract it?

 
  • Dr. Jarkko Rau­tio, University of East­ern Fin­land
    • 26.10.2021; Prodrug strategies to overcome problems in drug therapy
  • Dr. Susanne Bäck, Charles River, Kuo­pio
    • 2.11.2021; Animal models in drug discovery and development - a CRO perspective
  • Dr. Timo Myöhänen, University of East­ern Fin­land
    • 15.11.2021, NOTE ON MONDAY!, From inhibitors to ligands – PREP modulation in the models of neurodegenerative disease
  • Dr. Heidi Kidron, University of Helsinki
    • 23.11.2021, Cause and effect of variation in drug transporter activity
  • Dr. Robert Lux­en­hofer, University of Helsinki
    • 30.11.2021; Ultra-high loaded nanoformulations of poorly soluble drugs and drug candidates: Structure-property relationships, safety and efficacy
  • Dr. Ville Paavil­ainen, University of Helsinki
    • 7.12.2021
  • Dr. Matti Pou­tanen, University of Turku
    • 14.12.2021; HSD17B-enzymes: Potential drug targets for modulating of steroid and lipid synthesis
  • Prof. Vânia M. Mor­eira (Uni­ver­sid­ade de Coim­bra, Por­tugal)
    • 12.01.2021: Ex­plor­a­tions into the medi­cinal chemistry of the abi­etanes: a tale of in­nov­at­ive an­ti­mi­cro­bial com­pounds and materials
  • Prof. João F. Pinto (Uni­ver­sid­ade de Lis­boa, Por­tugal)
    • 19.01.2021: Ad­dit­ive Man­u­fac­ture of Medi­cines – 3D Print­ing, the 4th in­dus­trial re­volu­tion in man­u­fac­ture
  • Prof. Mi­chael Court­ney (University of Turku, Fin­land)
    • 02.02.2021: Identi­fy­ing and mon­it­or­ing drug­gable path­ways in neur­ons
  • Prof. Bruno Sar­mento (i3S - University of Porto, Por­tugal)
    • 09.02.2021: Cell-based in vitro mod­els for the val­id­a­tion of no-sys­temic drug de­liv­ery
  • Dr. Bert van Veen (Or­ion Pharma - Bio­phar­ma­ceut­ics, Fin­land)
    • 16.02.2021: Evol­u­tion of small chem­ical en­tit­ies to­wards amorph­ous solid dis­per­sions
  • Prof. Tomi Ran­tamäki (University of Helsinki, Fin­land)
    • 02.03.2021: Rapid-act­ing an­ti­de­press­ants and sleep
  • Prof. Jyrki Heinämäki (University of Tartu, Es­to­nia)
    • 09.03.2021: Needle­less elec­tro­spin­ning of nan­ofibers
  • Dr Christine-Maria Horejs (Chief Ed­itor, Nature Re­views Materials)
    • 30.03.2021: Sci­entific writ­ing and pub­lish­ing – in­sights from an ed­itor
  • Prof. Hongbo Zhang (Åbo Aka­demi University, Fin­land)
    • 06.04.2021: Func­tional Materials in Bio­med­ical En­gin­eer­ing
  • Dr. Vimalku­mar Balas­ub­ramanian (Bayer Oy, Fin­land)
    • 20.04.2021: Nanomedi­cine in Pharma per­spect­ive: past, present and fu­ture
  • Prof. Luca Ca­se­ttari (University of Urbino, Italy)
    • 11.05.2021: 3DP: from nano to devices
  • Prof. Tam­bet Teesalu (University of Tartu, Es­to­nia)
    • 18.05.2021: Hom­ing pep­tides and pre­ci­sion nanomedi­cine
  • Prof. Christel Bergström (Uppsala University, Sweden)
    • 29.9.2020 The vir­tual in­test­ine – a sim­u­la­tion en­vir­on­ment to un­der­stand ad­vanced drug de­liv­ery
  • Dr. Mia Bengt­ström (Pharma In­dustry Fin­land)
    • 7.10.2020 Pharma In­dustry Finland
  • Prof. Natasa Skalko-Bas­net (University of Tromsø, Nor­way)
    • 13.10.2020 Treat­ing gen­ital in­fec­tions: is current treat­ment the best we can do?
  • Dr. Ruth Schmid (SIN­TEF AS, Nor­way)
    • 21.10.2020 Ul­tra­sound-en­hanced drug de­liv­ery us­ing nan­o­particle-sta­bil­ized mi­cro­bubbles
  • Dr. Sara Cordeiro (Queen's University Bel­fast, North­ern Ire­land)
    • 3.11.2020 Mi­croar­ray patches for trans­dermal drug de­liv­ery and dia­gnostic ap­proaches